Ghana: Ghana First to Approve Oxford Malaria Vaccine
[DW] An Oxford University malaria vaccine has been approved for use in Ghana. The African country is ramping up efforts to combat the mosquito-borne disease that kills a child every minute. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 13, 2023 Category: African Health Source Type: news
Oxford University, Serum Institute of India tie-up delivers 'high efficacy' malaria vaccine
The R21/Matrix-M vaccine, leveraging Novavax's adjuvant technology, has been approved for use in children aged 5 to 36 months - the age group at the highest risk of death from malaria. It marks the first regulatory clearance for the R21/Matrix-M malaria vaccine for use in any country. (Source: The Economic Times)
Source: The Economic Times - April 13, 2023 Category: Consumer Health News Source Type: news
Ghana first to approve 'world-changer' malaria vaccine
The vaccine - R21 - was up to 80% effective in early-stage clinical trials. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 12, 2023 Category: Consumer Health News Source Type: news
News at a glance: Modernizing bed nets, IDing a Solar System visitor, and health lessons from Beethoven ’s hair
PUBLIC HEALTH
Next-gen bed nets get go-ahead
A new type of malaria-fighting bed net
received a major endorsement
from the World Health Organization (WHO) last week. The net combines two chemicals to more effectively kill the mosquitoes that transmit the parasite behind malaria, a disease that killed an estimated 619,000 people in 2022, most of them young children in sub-Saharan Africa. Insecticide-treated bed nets have helped drive malaria rates down dramatically. But in recent years, resistance to the insecticide used to treat nets, pyrethroid, has been spreading. That has contributed to ...
Source: ScienceNOW - March 23, 2023 Category: Science Source Type: news
Kenya: Kenya Rolls Out Vaccination Campaign Against Malaria
[VOA] Nairobi -- Kenya this week rolled out a campaign using the world's first vaccine against malaria to inoculate more than 400,000 children against the mosquito-borne disease. Health officials say malaria kills more than 12,000 Kenyans each year and more than half a million people in sub-Saharan Africa, most of them children. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 10, 2023 Category: African Health Source Type: news
Kenya: Kenya Expands Use of World's First Malaria Vaccine in Lake-Endemic Region
[PATH Malaria Vaccine Initiative] Nairobi -- Kenya's Ministry of Health announced that, starting on March 7, 2023, more children in the country will benefit from the added protection of the world's first malaria vaccine, RTS,S/AS01 (or RTS,S). The malaria vaccine expansion follows the Kenya National Immunization Technical Advisory Group (KENITAG) recommendation for expansion within Kenya's lake-endemic region and the 2021 World Health Organization (WHO) recommendation for broader use of the vaccine among children in sub-Saharan Africa and in other re (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - March 6, 2023 Category: Infectious Diseases Source Type: news
WHO art competition for school students & quot;75 years of improving public health & quot;
Dear students,
On 7 April 2023 ̶ World Health Day ̶ the World Health Organization will observe its 75th birthday.
In 1948, countries of the world came together and founded WHO to promote health, keep the world safe and serve the vulnerable – so everyone, everywhere could attain the highest level of health and well-being.
To advance the health and security of all people, WHO works with governments, communities, international organizations, foundations, advocates, researchers and health workers, and WHO’s 75th anniversary year is an opportunity to look back at the public health succe...
Source: WHO EMRO News - January 25, 2023 Category: Middle East Health Source Type: news
In Vitro Malaria Sporozoite Production May Lead to Cheaper Vaccines
A method for culturing the infectious stage of the Plasmodium lifecycle could increase malaria vaccine production efficiency by tenfold, study authors say. (Source: The Scientist)
Source: The Scientist - January 21, 2023 Category: Science Tags: News & Opinion Source Type: news
3-Dose Malaria Vaccine Shows Promise in African Trial
FRIDAY, Jan. 6, 2023 – New research has confirmed that a three-dose malaria vaccine is both safe and effective in West African adults, including those previously exposed to malaria.
Researchers at the University of Maryland Center for Vaccine... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 6, 2023 Category: General Medicine Source Type: news
10 Ways the World Got Better In 2022
Over the past year, the headlines have been dominated by alarming events: the Russian invasion of Ukraine, high inflation, supply chain shortages, and the threat of food insecurity for many nations. But 2022 was also a year of milestones toward a better future, scientific breakthroughs, and stories of hope. Here’s a look at 10 stories of human progress from the last 12 months.
1. We found out that civilization reached peak agricultural land
For nearly all of human history, producing more food required more land. But starting in the early 1900s, and continuing through the next 100 years, four powerful forces—syn...
Source: TIME: Health - December 28, 2022 Category: Consumer Health News Authors: Tony Morley Tags: Uncategorized climate change freelance global health Health Care healthscienceclimate Londontime Source Type: news
Africa: 2022 Year in Health - New Ebola and Cholera Outbreaks, MPox Emergency, Covid-19 'Not Over'
[UN News] The UN warned that the COVID-19 pandemic is still a cause for global concern, and outbreaks of cholera, Ebola and Monkeypox (now renamed mpox) led to the mobilization of health and aid workers to contain life-threatening illnesses. The UN warned that the aim of eradicating HIV/AIDS by 2030 was under threat, but a new vaccine raised hopes that malaria can be beaten. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 28, 2022 Category: African Health Source Type: news
Dr. Anthony Fauci Is Stepping Down. Here ’s His Advice For His Successor
After Dr. Anthony Fauci steps down as head of the National Institute of Allergy and Infectious Diseases (NIAID) and chief medical advisor to President Biden on Dec. 31, he’ll leave behind a long and storied career. Ahead of his last day, he spoke to TIME from his office at the National Institutes of Health about what’s next for him—and his advice for whoever fills his shoes.
This interview has been edited and condensed for clarity.
TIME: You’re leaving your leadership positions in the federal government, but you aren’t retiring. What are you calling the next stage in your career?
[time-brightc...
Source: TIME: Health - December 20, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Malawi: WHO, Malawi Roll Out Children's Malaria Vaccine
[VOA] Blantyre, Malawi -- Malawi and the World Health Organization are rolling out a new malaria vaccine for young children that backers say will reduce deaths from the mosquito-borne disease. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 1, 2022 Category: African Health Source Type: news
Malawi: Govt to Roll Out Malaria Vaccine
[Nyasa Times] Malawi's Malaria Control Programme has disclosed that it will officially roll out malaria vaccine to the remaining areas of the targeted districts on November 29 in Mchinji district. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - November 24, 2022 Category: Infectious Diseases Source Type: news
New data buoy hopes for promising malaria vaccine —but questions remain
A new vaccine against malaria showed promising preliminary results in a large trial in four African countries, boosting hopes that an additional tool may soon be available to help control the deadly disease. The vaccine, named R21/Matrix-M and developed by researchers at the University of Oxford,
produced similarly impressive results in a small trial
last year
, but the current study posed a stiffer test of its protection.
Initial data from the trial, reported yesterday at the American Society of Tropical Medicine and Hygiene meeting in Seattle, suggest the vaccine had an efficacy higher than 70% in...
Source: ScienceNOW - November 3, 2022 Category: Science Source Type: news
